Global Aclidinium Bromide Market Is Expected To Grow At A CAGR of 4.1% From 2020 To 2027

Aclidinium bromide is classified as a long-acting inhaled muscarinic antagonist that is prescribed for the long term maintenance treatment of chronic obstructive pulmonary disorders such as chronic bronchitis and emphysema. The constant rise in air pollution and cigarette smokers together drive the aclidinium bromide market growth. Aclidinium Bromide 400mcg/Actuation is reigning the formulation segment for […]